Managed Access Programs


The FarmaMondo Group supports biopharmaceutical companies in their mission to extend greater access for their medicines by ethically supplying product to patients in markets where it has not been commercially launched yet, through the global implementation of solid and sustainable Managed Access Programs, including Named Patient Supply services.

Being a preferred provider of Unlicensed Medicines to thousands of HCPs globally seeking ethical access to unavailable therapies, the Group’s network and geographical footprint supports wider access options for the Biopharma.

The Group offers both Paid access and No-charge access Programs through a comprehensive service package with a fair financial structure and flexible deal terms.


  • If you would like to send us a general enquiry, please complete the following form.